Drawing for ZEGRAMAX

USPTO serial 78293336

ZEGRAMAX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
RICHARDS, LESLIE
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ZEGRAMAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Wm. Charles Saunders

Wm. Charles Saunders AstraZeneca Pharmaceuticals LP1800 Concord PikeOW2Wilmington, DE 19850

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for use in the treatment of cancer; pharmaceutical preparations and substances for use in the treatment of infection; pharmaceutical preparations and substances for use in treating diseases and disorders of the nervous system; pharmaceutical preparations and substances for use in treating diseases and disorders of the urological system; pharmaceutical preparations and substances for use in treating diseases and disorders of the cardiovascular system; pharmaceutical preparations and substances for use in treating respiratory disorders and diseases; pharmaceutical preparations and substances for use in pain control and anaesthesia, none of the aforesaid goods being diagnostic preparations or for use in diagnostic processesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 17, 2009MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 17, 2009ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 19, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 19, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 19, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 17, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 17, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 17, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 14, 2008DOCKASSIGNED TO EXAMINER—
Oct 11, 2007RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 24, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 9, 2007RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 9, 2007ALIEASSIGNED TO LIE—
Sep 20, 2006RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 20, 2006CNSLLETTER OF SUSPENSION MAILED—
Mar 17, 2006CNSLSUSPENSION LETTER WRITTEN—
Jan 26, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 9, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 9, 2006MAILPAPER RECEIVED—
Aug 12, 2005CNSLLETTER OF SUSPENSION MAILED—
Aug 11, 2005CNSLSUSPENSION LETTER WRITTEN—
Sep 24, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Aug 30, 2004UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Aug 30, 2004MAILPAPER RECEIVED—
Aug 11, 20041.BDSec. 1(B) CLAIM DELETED—
Aug 11, 2004MAILPAPER RECEIVED—
Feb 9, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2004DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance